PSA Screening in 2023
Gerald L. Andriole, Jr., MD, Director of Urology in the National Capital Region at the Brady Urologic Institute at Johns Hopkins University, reviews evidence supporting a more comprehensive family history and biomarkers in screening and treating prostate cancer. He provides his insights on identifying patients with clinically significant PCa earlier, reducing unnecessary initial and repeat prostate biopsies.
Видео PSA Screening in 2023 канала Grand Rounds in Urology
Видео PSA Screening in 2023 канала Grand Rounds in Urology
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Accuracy of ExactVu Micro-Ultrasound for Diagnosis of Prostate Cancer
Minimally-Invasive Management of Symptomatic Caliceal Diverticular Stones
Radiologic Perspective on the Clinical Utility of and Emerging Data on Micro-Ultrasound
Neoadjuvant vs. Adjuvant vs. None – “Perioperative Therapy”
PSMA PET Imaging at Time of Diagnosis
The ENGAGEMENT Study - Virtual Genetics Board for Improving Prostate Cancer Genetic Testing
Androgen Targeted Therapy Across the Continuum of Prostate Cancer
Management of Recurrent Prostate Cancer After Focal Therapy
Join us for IPCU 33 in Vail CO, January 22-25, 2023
Case Discussion: Early Detection of Prostate Cancer 2023
The Case for Standard Imaging
IPCU Session 1 Review: Men's Prostate Health
Bottom Line Shrinking? Check Your EOBs
Socioeconomic Aspects of Prostate Brachytherapy
Non-Muscle Invasive Bladder Cancer: Guidelines-Based Approach
Pathologist's Perspective on Focal Therapy
In My Opinion - The Future of Independent Practice
Contemporary Management of Recurrent Idiopathic Priapism
Garnick - Review of the New Standard in Treatment and Global Issues
Financial Toxicity